USEFULNESS OF FIB-4 INDEX AND ALT AT 1 YEAR OF NUCLEOS(T) IDE ANALOG TREATMENT FOR PREDICTION OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS

被引：0
|
作者：
Inoue, Jun [1 ]
Akahane, Takehiro [2 ]
Kobayashi, Tomoo [3 ]
Kimura, Osamu [4 ]
Sato, Kosuke [1 ]
Ninomiya, Masashi [1 ]
Iwata, Tomoaki [1 ]
Takai, Satoshi [5 ]
Kisara, Norihiro [6 ]
Sato, Toshihiro [7 ]
Nagasaki, Futoshi [8 ]
Miura, Masahito [9 ]
Nakamura, Takuya [10 ]
Umetsu, Teruyuki [11 ]
Sano, Akitoshi [1 ]
Tsuruoka, Mio [1 ]
Onuki, Masazumi [1 ]
Sawahashi, Satoko [1 ]
Niitsuma, Hirofumi [1 ]
Masamune, Atsushi [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
[2] Japanese Red Cross Ishinomaki Hosp, Ishinomaki, Miyagi, Japan
[3] Tohoku Rosai Hosp, Sendai, Miyagi, Japan
[4] South Miyagi Med Ctr, Sendai, Miyagi, Japan
[5] Iwaki City Med Ctr, Iwaki, Fukushima, Japan
[6] Japan Community Hlth Care Org Sendai South Hosp, Sendai, Miyagi, Japan
[7] LC Clin, Sendai, Miyagi, Japan
[8] Sendai City Hosp, Sendai, Miyagi, Japan
[9] Omagari Kousei Med Ctr, Daisen, Akita, Japan
[10] Yamagata City Hosp Saiseikan, Yamagata, Japan
[11] Kesennuma City Hosp, Kesennuma, Miyagi, Japan
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1450-C
引用
收藏
页码：S550 / S550
页数：1
相关论文
共 50 条
  • [31] Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
    Terry Cheuk-Fung Yip
    Jimmy Che-To Lai
    Grace Lai-Hung Wong
    Journal of Gastroenterology, 2020, 55 : 1023 - 1036
  • [32] Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
    Lee, I-Cheng
    Sun, Cheuk-Kay
    Su, Chien-Wei
    Wang, Yuan-Jen
    Chang, Hung-Chuen
    Huang, Hui-Chun
    Lee, Kuei-Chuan
    Huang, Yi-Shin
    Perng, Chin-Lin
    Liu, Yuh-Hwa
    Chua, Chian-Sem
    Lin, Yu-Min
    Lin, Han-Chieh
    Huang, Yi-Hsiang
    MEDICINE, 2015, 94 (32)
  • [33] High Liver Fibrosis Index FIB-4 Is Highly Predictive of Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
    Suh, Beomseok
    Park, Sehhoon
    Shin, Dong Wook
    Yun, Jae Moon
    Yang, Hyung-Kook
    Yu, Su Jong
    Shin, Cheong-Il
    Kim, Jin-Soo
    Ahn, Eunmi
    Lee, Hyejin
    Park, Jin Ho
    Cho, BeLong
    HEPATOLOGY, 2015, 61 (04) : 1261 - 1268
  • [34] TRANSIENT ELASTOGRAPHY IS SUPERIOR TO FIB-4 IN ASSESSING THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B
    Kim, B. K.
    Kim, S. U.
    Park, J. Y.
    Kim, D. Y.
    Ahn, S. H.
    Song, K.
    Han, K. -H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S718 - S718
  • [35] Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Kim, Seung Up
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Song, Kijun
    Han, Kwang-Hyub
    MEDICINE, 2016, 95 (20)
  • [36] Deciphering the dual nature of the Fibrosis-4 index in predicting hepatocellular carcinoma risk among hepatitis B patients undergoing nucleos(t)ide analog therapy
    Arai, Jun
    Ito, Kiyoaki
    HEPATOLOGY RESEARCH, 2024, 54 (02) : 120 - 121
  • [37] Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment
    Wakasugi, Hideki
    Takahashi, Hideaki
    Niinuma, Takeshi
    Kitajima, Hiroshi
    Oikawa, Ritsuko
    Matsumoto, Naoki
    Takeba, Yuko
    Otsubo, Takehito
    Takagi, Masayuki
    Ariizumi, Yasushi
    Suzuki, Michihiro
    Okuse, Chiaki
    Iwabuchi, Shogo
    Nakano, Masayuki
    Akutsu, Noriyuki
    Kang, Jong-Hon
    Matsui, Takeshi
    Yamada, Norie
    Sasaki, Hajime
    Yamamoto, Eiichiro
    Kai, Masahiro
    Sasaki, Yasushi
    Sasaki, Shigeru
    Tanaka, Yasuhito
    Yotsuyanagi, Hiroshi
    Tsutsumi, Takeya
    Yamamoto, Hiroyuki
    Tokino, Takashi
    Nakase, Hiroshi
    Suzuki, Hiromu
    Itoh, Fumio
    CANCER LETTERS, 2018, 434 : 91 - 100
  • [38] Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment
    Ando, Yusuke
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Hayashi, Kazuhiko
    Ishikawa, Tetsuya
    Nakano, Isao
    Hirooka, Yoshiki
    Goto, Hidemi
    HEPATOLOGY RESEARCH, 2018, 48 (03) : E240 - E251
  • [39] Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk
    Ren, Peipei
    Cao, Zhujun
    Mo, Ruidong
    Liu, Yuhan
    Chen, Lichang
    Li, Ziqiang
    Zhou, Tianhui
    Lu, Jie
    Liu, Yunye
    Guo, Qing
    Chen, Rong
    Zhou, Huijuan
    Xiang, Xiaogang
    Cai, Wei
    Wang, Hui
    Bao, Shisan
    Xu, Yumin
    Gui, Honglian
    Xie, Qing
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1085 - 1094
  • [40] Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Hiyama, Yuichi
    Fujino, Hatsue
    Namba, Maiko
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Oka, Shiro
    HEPATOLOGY RESEARCH, 2024, 54 (11) : 981 - 992
12345